360 related articles for article (PubMed ID: 18937325)
1. Humoral immune response after post-chemotherapy booster diphtheria-tetanus-pertussis vaccine in pediatric oncology patients.
Cheng FW; Leung TF; Chan PK; Lee V; Shing MK; Chik KW; Yuen PM; Li CK
Pediatr Blood Cancer; 2009 Feb; 52(2):248-53. PubMed ID: 18937325
[TBL] [Abstract][Full Text] [Related]
2. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
[TBL] [Abstract][Full Text] [Related]
3. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
Zengin E; Sarper N
Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
[TBL] [Abstract][Full Text] [Related]
4. Recovery of humoral and cellular immunities to vaccine-preventable infectious diseases in pediatric oncology patients.
Cheng FW; Leung TF; Chan PK; Leung WK; Lee V; Shing MK; Yuen PM; Li CK
Pediatr Hematol Oncol; 2010 Apr; 27(3):195-204. PubMed ID: 20367263
[TBL] [Abstract][Full Text] [Related]
5. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
[TBL] [Abstract][Full Text] [Related]
6. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
[TBL] [Abstract][Full Text] [Related]
7. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
McCusker C; Somerville W; Grey V; Mazer B
Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
[TBL] [Abstract][Full Text] [Related]
8. Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.
Abzug MJ; Song LY; Fenton T; Nachman SA; Levin MJ; Rosenblatt HM; Pelton SI; Borkowsky W; Edwards KM; Peters J;
Pediatrics; 2007 Nov; 120(5):e1190-202. PubMed ID: 17938165
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents.
Huang LM; Chang LY; Tang H; Bock HL; Lu CY; Huang FY; Lin TY; Lee CY
J Adolesc Health; 2005 Dec; 37(6):517. PubMed ID: 16310132
[TBL] [Abstract][Full Text] [Related]
10. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
Chan SH; Tan PT; Han HH; Bock HL
Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
[TBL] [Abstract][Full Text] [Related]
12. Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection.
Rosenblatt HM; Song LY; Nachman SA; Stanley KE; Krogstad PA; Johnson GM; Wiznia AA;
J Allergy Clin Immunol; 2005 Sep; 116(3):698-703. PubMed ID: 16159645
[TBL] [Abstract][Full Text] [Related]
13. Antibody response after measles immunization.
Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
[TBL] [Abstract][Full Text] [Related]
14. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian preschool children.
Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Kheirkhah T; Ghazanfari M; Shokri F
Iran J Immunol; 2007 Jun; 4(2):101-9. PubMed ID: 17652850
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
Thisyakorn U; Pancharoen C; Chuenkitmongkol S; Ortiz E
Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):282-94. PubMed ID: 19323013
[TBL] [Abstract][Full Text] [Related]
17. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia.
Ercan TE; Soycan LY; Apak H; Celkan T; Ozkan A; Akdenizli E; Kasapçopur O; Yildiz I
J Pediatr Hematol Oncol; 2005 May; 27(5):273-7. PubMed ID: 15891564
[TBL] [Abstract][Full Text] [Related]
18. Immunity to pertussis 5 years after booster immunization during adolescence.
Edelman K; He Q; Mäkinen J; Sahlberg A; Haanperä M; Schuerman L; Wolter J; Mertsola J
Clin Infect Dis; 2007 May; 44(10):1271-7. PubMed ID: 17443462
[TBL] [Abstract][Full Text] [Related]
19. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
[TBL] [Abstract][Full Text] [Related]
20. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
